Dr. Horowitz is a gynecologic oncologist at Brigham and Women’s Hospital/Dana Farber Cancer Institute in Boston, MA. He did his residency training at the University of Washington Medical Center in Seattle, WA, followed by a fellowship at Washington University /Barnes Jewish Hospital. He currently is the Director of Clinical Research for the Division of Gynecologic Oncology at Brigham and Women’s Hospital and an Assistant Professor in Obstetrics, Gynecology, and Reproductive Medicine at Harvard Medical School. He is an active and full member of several organizations including the Society of Gynecologic Oncology and Gynecologic Oncology Group.
Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.
Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.
The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.